Cargando…

PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer

Detalles Bibliográficos
Autores principales: Curtin, Nicola, Bai, Péter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760776/
https://www.ncbi.nlm.nih.gov/pubmed/33255262
http://dx.doi.org/10.3390/cancers12123494
_version_ 1783627413202141184
author Curtin, Nicola
Bai, Péter
author_facet Curtin, Nicola
Bai, Péter
author_sort Curtin, Nicola
collection PubMed
description
format Online
Article
Text
id pubmed-7760776
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77607762020-12-26 PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer Curtin, Nicola Bai, Péter Cancers (Basel) Editorial MDPI 2020-11-24 /pmc/articles/PMC7760776/ /pubmed/33255262 http://dx.doi.org/10.3390/cancers12123494 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Curtin, Nicola
Bai, Péter
PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer
title PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer
title_full PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer
title_fullStr PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer
title_full_unstemmed PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer
title_short PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer
title_sort parps, par and nad metabolism and their inhibitors in cancer
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760776/
https://www.ncbi.nlm.nih.gov/pubmed/33255262
http://dx.doi.org/10.3390/cancers12123494
work_keys_str_mv AT curtinnicola parpsparandnadmetabolismandtheirinhibitorsincancer
AT baipeter parpsparandnadmetabolismandtheirinhibitorsincancer